This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Genincode Plc. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Marta Carrera: Innovator in Cardiovascular Risk Assessment
Introduction
Marta Carrera is a prominent inventor based in Barcelona, Spain. She has made significant contributions to the field of cardiovascular health through her innovative research and inventions. Her work focuses on improving risk assessment methods for cardiovascular diseases, which can lead to better patient outcomes.
Latest Patents
Marta Carrera holds a patent for a method related to risk assessment for cardiovascular disease. This invention involves reclassifying a subject to a more appropriate risk assessment than that obtained using traditional algorithms such as Framingham, Regicor, Score, Procam, or Qrisk. The method combines the presence or absence of various polymorphic markers with conventional risk factors for cardiovascular disease. This innovative approach enhances the accuracy of risk determination and can be implemented through computer-based methods.
Career Highlights
Marta Carrera is associated with Genincode Plc, where she applies her expertise in genetics and cardiovascular health. Her work at the company has been instrumental in advancing the understanding of genetic factors that influence cardiovascular risk. With her dedication to research and innovation, she continues to make strides in the medical field.
Collaborations
Marta has collaborated with notable colleagues, including Matthew Heaton Walls and Jaume Marrugat De La Iglesia. These partnerships have enriched her research and contributed to the development of her innovative methods.
Conclusion
Marta Carrera's contributions to cardiovascular risk assessment highlight her role as a leading inventor in the medical field. Her innovative methods have the potential to significantly improve patient care and outcomes in cardiovascular health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile